[O7] Oral Session 7　Gastrointestinal Cancer 2（Lower GI Tract-Colorectal Cancer 1）
【E】

[O7-5] Exploratory analysis of baseline tumor burden in the TRUSTY study: Phase 2/3 study of 2nd-line FTD/TPI + BEV for mCRC

^○Masato Nakamura¹, Yasutoshi Kuboki², Tetsuji Terazawa³, Toshiki Masuishi⁴, Jun Watanabe⁵, Hitoshi Ojima⁶, Akitaka Makiyama^7,8, Masahito Kotaka⁹, Hiroki Hara¹⁰, Takashi Ohta¹¹, Eiji Oki¹², Yu Sunakawa¹³, Soichiro Ishihara¹⁴, Hiroya Taniguchi⁴, Takako Eguchi Nakajima¹⁵, Satoshi Morita¹⁶, Kuniaki Shirao¹⁷, Takayuki Yoshino¹⁸ (1.Aizawa Comprehensive Cancer Center, Aizawa Hospital, 2.Department of Experimental Therapeutics, National Cancer Center Hospital East, 3.Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, 4.Department of Clinical Oncology, Aichi Cancer Center Hospital, 5.Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, 6.Gastrointestinal Surgery, Gunma Prefectural Cancer Center, 7.Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, 8.Cancer Center, Gifu University Hospital, 9.Gastrointestinal Cancer Center, Sano Hospital, 10.Department of Gastroenterology, Saitama Cancer Center, 11.Department of Clinical Oncology, Kansai Rosai Hospital, 12.Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 13.Department of Clinical Oncology, St. Marianna University School of Medicine, 14.Department of Surgical Oncology, The University of Tokyo, 15.Department of Early Clinical Development, Kyoto University Graduate School of Medicine, 16.Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, 17.Oita University Faculty of Medicine, 18.Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East)